As contemporary surgical practice continues to evolve, patients who undergo surgical lung volume reduction (LVRS) for ...

The FDA has issued a complete response letter to the biologics license application seeking the approval of tabelecleucel for ...

Guillain-Barré Syndrome (GBS) is a rare neurological disorder where the immune system attacks nerves. Learn about symptoms, ...

Guillain Barré Syndrome overview: symptoms, causes, treatment, and potential complications, including recent outbreak in Pune ...

The U.S. Food and Drug Administration on Thursday declined to approve Atara Biotherapeutics' therapy to treat patients with a ...

This COPD Awareness Month, NuvoAir Medical is here to guide you through your COPD management journey with weekly content drops. 📅 This week, we’re focusing on the critical aspects of ...

India's first Guillain-Barre Syndrome death reported in Maharashtra—what’s causing the outbreak, who’s at risk. Read on to ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr ...

After acyclovir therapy, her clinical symptoms resolved with negative EBV-DNA, and she was discharged home with aspirin treatment for the remaining CALs. However, she did not have regular follow-ups ...

The FDA has said it cannot approve tabelecleucel to treat patients 2 years of age and older who have EBV-positive PTLD and have received at least 1 prior therapy.

Maharashtra's health department has reported over 100 cases of Guillain-Barré Syndrome (GBS) in Pune, with one suspected ...